ArticleMediterranean journal of hematology and infectious diseases2022

Efficacy and Safety of Sinopharm Vaccine for SARS-CoV-2 and breakthrough infections in Iranian Patients with Hemoglobinopathies: A Preliminary Report.

Mehran Karimi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.